|
Match
|
Document |
Document Title |
|
|
8183281 |
CXC-chemokine receptor ligands
The present invention relates to compounds of formula (I) with the substituents as defined herein, and uses thereof.
|
|
|
8158677 |
Treatment of viral infections by modulation of host cell metabolic pathways
Alterations of certain metabolite concentrations and fluxes that occur in response to viral infection are described. Host cell enzymes in the involved metabolic pathways are selected as targets for...
|
|
|
8153667 |
Tricyclic aromatic and bis-phenyl sulfinyl derivatives
The present invention provides compounds of the structure: wherein the constituent members are defined herein, including pharmaceutical compositions thereof and methods of treating diseases therewith.
|
|
|
8138222 |
Whitening agents for cellulosic substrates
This invention relates to novel whitening agents for cellulosic substrates. The whitening agents are comprised of at least two components: at least one chromophore component and at least one...
|
|
|
8119685 |
Disubstituted aniline compounds
The present invention relates to a novel class of disubstituted aniline compounds. These compounds can inhibit histone deacetylase and are suitable for use in selectively inducing terminal...
|
|
|
8093253 |
Leukotriene B4 inhibitors
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and...
|
|
|
8088804 |
N-hydroxyamide derivatives possessing antibacterial activity
Described herein are N-hydroxyamide antibacterial compounds, methods for making the compounds, pharmaceutical compositions containing the compounds and methods of treating bacterial infections...
|
|
|
8088819 |
Derivatives of substituted 3-phenyl-1-(phenylthienyl)propan-1-ones and of 3-phenyl-1-(phenylfuranyl) propan-1-ones, preparation and use
The present invention relates to compounds derived from substituted 3-phenyl-1-(thien-2-yl)propan-1-ones, pharmaceutical compositions comprising them as well as their therapeutic applications,...
|
|
|
8084452 |
Substituted enaminocarbonyl compounds used as insecticides
The present application relates to novel substituted enaminocarbonyl compounds, to processes for their preparation and to their use for controlling animal pests, especially arthropods, in...
|
|
|
8063067 |
Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
Compounds of the formula (I): in which R, R1, R2 and R3 are as defined in the description, the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical...
|
|
|
8053439 |
Benzophenone derivatives useful for inhibiting formation of microtubule
Disclosed herein are novel benzophenone derivatives represented by formula I, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, a pharmacological composition...
|
|
|
8039493 |
Biaryl sulfonamide derivatives
The invention is concerned with novel biaryl sulfonamide derivatives of formula (I) wherein R1 to R3 and Y are as defined in the description and in the claims, as well as physiologically acceptable...
|
|
|
8026275 |
Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
The present invention provides novel 2,6-diisopropyl phenol2,6-diisopropyl phenol analogs and sterile, stable pharmaceutical compositions of 2,6-diisopropyl phenol 2,6-diisopropyl phenol and...
|
|
|
8022100 |
Whitening agents for cellulosic substrates
This invention relates to novel whitening agents for cellulosic substrates. The whitening agents are comprised of at least two components: at least one chromophore component and at least one...
|
|
|
8017558 |
Carboxamides for controlling micro-organisms in plant and material protection
Novel carboxamides of the formula (I) The present application is further directed toward a plurality of processes for preparing these compounds and their use for controlling unwanted...
|
|
|
8003680 |
Therapeutic compounds
Disclosed herein are compounds of the formula therapeutic methods, compositions, and medicaments related thereto are also disclosed.
|
|
|
7998965 |
Glutamate aggrecanase inhibitors
The present invention relates to modulators of metalloproteinase activity.
|
|
|
7985767 |
Therapeutic amides
Compounds of the formula are disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
|
|
|
7981907 |
Thio-substituted biarylmethanesulfinyl derivatives
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that...
|
|
|
7981874 |
Phosphorus derivatives as histone deacetylase inhibitors
The present invention relates to a novel class of phosphorus derivatives. The phosphorus compounds can be used to treat cancer. The phosphorus compounds can also inhibit histone deacetylase and are...
|
|
|
7977374 |
Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or stereoisomer thereof. The compounds of the present invention are inhibitors of histone...
|
|
|
7977370 |
(Hetero)aryl cyclohexane derivatives
The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these ...
|
|
|
7951806 |
Plasminogen activator inhibitor-1 inhibitor
The present invention relates to an inhibitor of plasminogen activator inhibitor-1. The present invention further relates to a pharmaceutical composition that has an inhibitory action on PAI-1...
|
|
|
7951837 |
Crystalline forms of duloxetine free base
The present invention is concerned with duloxetine free base in crystalline form, and also novel polymorphic forms thereof.
|
|
|
7935696 |
Heterocyclic amide compounds useful as kinase inhibitors
A compound of Formula I and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods...
|
|
|
7928129 |
Nanomolar β-lactamase inhibitors
New carboxyphenyl-glycylboronic acid transition-state analog inhibitors, representative of a class of compounds effective against class C β-lactamase AmpC. The new compounds improve inhibition by ...
|
|
|
7906552 |
Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof, having the groups described in detail herein is disclosed. Also disclosed herein are compounds comprising or...
|
|
|
7872041 |
Use of rotigotine for treating and preventing Parkinson's plus syndrome
The invention relates to the use of rotigotine, its salts and prodrugs, as a medicament for preventing and/or treating Parkinson's plus syndrome.
|
|
|
7863319 |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
A compound comprising or a pharmaceutically acceptable salt or a prodrug thereof,having the groups described in detail herein is disclosed. Also disclosed herein are compounds comprising or...
|
|
|
7863318 |
Prostaglandins and analogues as agents for lowering intraocular pressure
The present invention relates to cyclopentane heptenoic acid-5-cis-2-(3α-hydroxy or lower alkyloxy-5-thienylpentyl)-3, 5-dihydroxy, [1α, 2β, 3α, 5α] compounds, lower alkyl, hydroxyl lower alky...
|
|
|
7858658 |
Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted...
|
|
|
7855232 |
Organoselenium compound for cancer chemoprevention
A compound containing an alkylene selenocyanate or an alkylene isoselenocyanate moiety effective to prevent the occurrence or progression of cancer or a precancerous condition. The compound can be...
|
|
|
7851501 |
Aromatic nitrocatechol compounds and their use for modulating processes mediated by cell adhesion molecules
Pharmaceutical compositions comprising at least one compound of e.g. the formulas (Ie) and a pharmaceutically acceptable carrier which is useful in a medicine wherein the symbols and substituents...
|
|
|
7842717 |
DNT-maleate and methods of preparation thereof
(S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanam
ine maleate (DNT-maleate) and polymorphs of DNT-maleate, compositions of DNT-maleate and its polymorphs, processes for the preparation...
|
|
|
7838020 |
Cosmetic or dermatological composition comprising an association between a compound of the N-acylaminoamide family and at least one matrix metalloproteinase inhibitor
A cosmetic or dermatological composition characterized in that it comprises an association between an elastase inhibitor compound of the N-acylaminoamide family and at least one metalloproteinase...
|
|
|
7834013 |
Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
The present invention relates generally to novel therapeutic compounds and more particularly to novel compounds, their use as GPR40 agonists, processes for their manufacture, and intermediates...
|
|
|
7825154 |
Small molecule inhibitors of botulinum neurotoxins
Disclosed herein are methods of inhibiting the activity of Botulinum neurotoxin A metalloprotease with the compounds disclosed herein. Also disclosed are methods of treating, inhibiting or...
|
|
|
7803798 |
Therapeutic compounds
Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, D, and Y are as described. Methods, compositions, and medicaments related thereto are...
|
|
|
7803797 |
Substituted arylcyclopentenes as therapeutic agents
Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are...
|
|
|
7795315 |
N-(2-amino-phenyl)-amide derivatives
The present invention provides novel compounds of the general formula (I) and pharmaceutically acceptable salts thereof, processes for the manufacture of these novel compounds and medicaments...
|
|
|
7790758 |
Compounds which potentiate glutamate receptor and uses thereof in medicine
This invention relates to potentiation of the glutamate receptor by novel compounds of formula (I): The invention also relates to the use of the derivatives in treating diseases and conditions...
|
|
|
7776922 |
Substituted [(phenylethanoyl)amino]benzamides
The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of...
|
|
|
7749990 |
Compositions for the treatment of metabolic disorders
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and...
|
|
|
7745445 |
Compounds and compositions as PPAR modulators
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of...
|
|
|
7745456 |
Synthesis and antimicrobial activity of novel dicationic “reversed amidines”
The present invention relates to novel 2,5-bis{[alkyl (or aryl) imino] aminophenyl}furans and thiophenes of the general formula in which R1, R2, R3 and R4 are each independently selected from the...
|
|
|
7741323 |
Indene derivatives and process for the preparation thereof
An indene derivative for selectively modulating the activities of peroxisome proliferator activated receptors (PPARs) having the following formula (I): wherein, R1 is C1-6 alkyl, C1-6 alkenyl, or...
|
|
|
7732483 |
DNA-PK inhibitors
A compound of formula I: and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R1 and R2 are independently selected from hydrogen, an optionally substituted C1-7...
|
|
|
7709507 |
Therapeutic fluoroethyl ureas
Compounds of the formula or a pharmaceutically acceptable salt thereof or a tautomer thereof, wherein A and B are as described herein, are useful for treating conditions afflicting mammals.
|
|
|
7705043 |
Substituted aminodicarboxylic acid derivatives having pharmaceutical properties
The invention relates to compounds of formula (I) and their salts and stereoisomers in which the variables are as defined in the description and claims, for producing medicaments used in the...
|
|
|
7691898 |
Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia
This invention related to a series of new phosphonic acid derivatives having anti-hyperphosphatemia activity. wherein: A is selected from —(CH2)n—, —CO—, —(CH2)n—CO—(CH2)m—, —(CH2)n—CS—(CH2...
|